Relenza


Also found in: Medical, Wikipedia.

Re·len·za

 (rə-lĕn′zə)
A trademark for the drug zanamivir.

Relenza

(rɪˈlɛnzə)
n
(Pharmacology) trademark a preparation of an antiviral drug, zanamivir, used in the treatment of influenza to reduce the duration and severity of the illness
References in periodicals archive ?
Swine flu has not yet developed resistance to Relenza, an inhaled form of anti-viral treatment.
Tamiflu and another anti-influenza drug, Relenza, focus on interrupting neuraminidase's ability to help influenza detach from an infected cell's surface by digesting sialic acid, a sugar on the surface of the cell.
7m in royalties from Biota's flue drug Relenza, due to the H1N1 pandemic, compared to royalties of AUD6.
The new deal also includes an undertaking to buy an as yet undefined amount of the H5N1 bird flu vaccine and anti-viral flu treatment Relenza.
This product is marketed worldwide by GlaxoSmithKline (GSK) (LSE:GSK) (NYSE:GSK) under the trade name Relenza.
Eight cold-storage trucks will deliver Tamiflu for 400,000 people and Relenza for 100,000 by an overland route across the western border between the two Koreas, Chun Hae Sung said in a press briefing.
The Unification Ministry, which handles cross-border ties, said the shipment would include antiviral drugs for 500,000 patients -- Tamiflu for 400,000 and Relenza for 100,000 -- and sanitation supplies.
A finales de abril pasado, en pleno caos por la epidemia de influenza AH1N1, cientificos, intelectuales y politicos mexicanos hablaron sobre la posibilidad de que se emitiera un decreto especial que liberara las patentes de Tamiflu (oseltamivir, un antiviral) y Relenza (zanamivir, un broncodilatador), para que cualquier laboratorio pudiera fabricarlos en Mexico, y hacer Frente al problema de salud publica.
The Scots pair made a full recovery after being treated with an alternative drug, Relenza.
Glaxo also produces the Relenza flu treatment and is hoping to produce around 190 million doses by the end of the year.
It has also developed one of the key treatments for the virus, Relenza, which it is manufacturing at a full capacity of six million doses.
The drugs worked a little better in people who had a high risk of complications, such as patients with diabetes or asthma, with Relenza cutting sickness by almost a day and Tamiflu by three-quarters of a day, on average.